Sorting nexin 2 (SNX2) controls drug sensitivity to molecular targeted anticancer agents through membrane trafficking of c-Met protein in cancer cell

被引：1
|
作者：
Ono, Mayumi [1 ]
Ogi, Sayaka [1 ]
Yamamoto, Chizuko [1 ]
Fujita, Hideaki [1 ]
Kuwano, Michihiko [1 ]
机构：
[1] Kyushu Univ, Grad Sch Pharmaceut Oncol, Fukuoka 812, Japan
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-1199
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1199
引用
收藏
页数：2
相关论文
共 8 条
  • [1] Sorting nexin 2-mediated membrane trafficking of c-Met contributes to sensitivity of molecular-targeted drugs
    Ogi, Sayaka
    Fujita, Hideaki
    Kashihara, Masaki
    Yamamoto, Chizuko
    Sonoda, Kahori
    Okamoto, Isamu
    Nakagawa, Kazuhiko
    Ohdo, Shigehiro
    Tanaka, Yoshitaka
    Kuwano, Michihiko
    Ono, Mayumi
    CANCER SCIENCE, 2013, 104 (05) : 573 - 583
  • [2] H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism
    Chen, Mei-Kuang
    Du, Yi
    Sun, Linlin
    Hsu, Jennifer L.
    Wang, Yu-Han
    Gao, Yuan
    Huang, Jiaxing
    Hung, Mien-Chie
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (21) : 8516 - 8528
  • [3] Molecular stratification of ER+/HER2-breast cancer cell lines to predict sensitivity to targeted agents
    Bathurst, L.
    Liao, L.
    Crozier, C.
    Lyttle, N.
    Marcellus, R.
    Bayani, J.
    Al-Awar, R.
    Bartlett, J.
    Spears, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [4] Molecular docking simulation, synthesis and 3D pharmacophore studies of novel 2-substituted-5-nitro-benzimidazole derivatives as anticancer agents targeting VEGFR-2 and c-Met
    Ibrahim, Heba A.
    Awadallah, Fadi M.
    Refaat, Hanan M.
    Amin, Kamilia M.
    BIOORGANIC CHEMISTRY, 2018, 77 : 457 - 470
  • [5] Preliminary efficacy of telisotuzumab vedotin (Teliso-V) treatment in the 2L/3L setting in MET gene amplified ( MET Amp), c-Met protein overexpressing (c-Met OE), nonsquamous, non-small cell lung cancer (NSQ NSCLC): Retrospective analysis of LUMINOSITY
    Camidge, D. Ross
    Goldman, Jonathan
    Vasilopoulos, Athan
    Ansell, Peter
    Xia, Summer
    Bolotin, Ellen
    Looman, Jim
    Ratajczak, Christine
    Noon, Elysa
    Lu, Shun
    CANCER RESEARCH, 2023, 83 (08)
  • [6] The Novel Anticancer Drug Hydroxytriolein Inhibits Lung Cancer Cell Proliferation via a Protein Kinase Cα- and Extracellular Signal-Regulated Kinase 1/2-Dependent Mechanisms
    Guardiola-Serrano, Francisca
    Beteta-Goebel, Roberto
    Rodriguez-Lorca, Raquel
    Ibarguren, Maitane
    Lopez, David J.
    Teres, Silvia
    Alvarez, Rafael
    Alonso-Sande, Maria
    Busquets, Xavier
    Escriba, Pablo V.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2015, 354 (02): : 213 - 224
  • [7] QSAR, molecular docking and ADMET properties in silico studies of novel 4,5,6,7-tetrahydrobenzo[D]-thiazol-2-Yl derivatives derived from dimedone as potent anti-tumor agents through inhibition of C-Met receptor tyrosine kinase
    Daoui, Ossama
    Elkhattabi, Souad
    Chtita, Samir
    Elkhalabi, Rachida
    Zgou, Hsaine
    Benjelloun, Adil Touimi
    HELIYON, 2021, 7 (07)
  • [8] Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI anticancer drug screen: Multifactorial relationships with topoisomerase I, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways
    Nieves-Neira, W
    Pommier, Y
    INTERNATIONAL JOURNAL OF CANCER, 1999, 82 (03) : 396 - 404
1